INFUSION SITE ULCER

This adverse event was reported 92 times

INFUSION SITE ULCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GARADACIMAB 1 0.0013
1 HUMAN IMMUNOGLOBULIN G 27 0.0013
2 IBRITUMOMAB TIUXETAN 1 0.0007
3 ROMIDEPSIN 1 0.0006
4 DACARBAZINE 4 0.0005
5 VINBLASTINE SULFATE 1 0.0005
6 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 2 0.0005
7 INSULIN LISPRO-AABC 1 0.0005
8 FOSCARBIDOPA/FOSLEVODOPA 4 0.0005
9 TRABECTEDIN 1 0.0004
See all drugs enriched for association with INFUSION SITE ULCER

INFUSION SITE ULCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 29 0.0014
1 Sigma-1 Agonist [EPC] 1 0.0001
2 Prostacycline Vasodilator [EPC] 12 0.0001
3 Ester Local Anesthetic [EPC] 4 0.0001
4 Amide Local Anesthetic [EPC] 5 0.0001
5 Phosphodiesterase 5 Inhibitor [EPC] 7 0.0001
6 Non-Standardized Chemical Allergen [EPC] 4 0.0001
7 Antiarrhythmic [EPC] 5 0.0001
8 Vitamin D3 Analog [EPC] 1 0.0000
9 General Anesthetic [EPC] 2 0.0000
See all drug classes enriched for association with INFUSION SITE ULCER